⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Liver Safety Under Upfront Arimidex vs Tamoxifen

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Liver Safety Under Upfront Arimidex vs Tamoxifen

Official Title: A Prospective, Randomized, Multicentre, Comparative and Open-label Study on Hepatotoxicity of ARIMIDEX Compared With Tamoxifen in Adjuvant Therapy in Postmenopausal Women With Hormone Receptor+ Early Breast Cancer

Study ID: NCT00537771

Conditions

Breast Cancer

Study Description

Brief Summary: The primary objective is to compare ARIMIDEX (anastrozole) 1 mg once daily with Tamoxifen 20 mg once daily as adjuvant treatment in terms of: incidence of fatty liver diseases. The second objectives are to compare ARIMIDEX (anastrozole) 1 mg once daily with Tamoxifen 20 mg once daily as adjuvant treatment in terms of: incidences of abnormal liver function test, and time to treatment failure.

Detailed Description:

Eligibility

Minimum Age:

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Research Site, Fuzhou, Fujian, China

Research Site, Guangzhou, Guangdong, China

Research Site, Nanning, Guangxi, China

Research Site, Wuchang, Hubei, China

Research Site, Wuhan, Hubei, China

Research Site, Nanjing, Jiangsu, China

Research Site, Changchun, Jilin, China

Research Site, Dalian, Liaoning, China

Research Site, Jinan, Shandong, China

Research Site, Shanghai, Shanghai, China

Research Site, Taiyuan, Shanxi, China

Research Site, Xian, Shanxi, China

Research Site, Chengdu, Sichuan, China

Research Site, Kunming, Yunnan, China

Research Site, Hangzhou, Zhejiang, China

Research Site, Tianjin, , China

Contact Details

Name: Vivian Gu

Affiliation: AstraZeneca

Role: STUDY_DIRECTOR

Name: Fengping Liang

Affiliation: AstraZeneca

Role: STUDY_CHAIR

Name: Prof. Wang Shenming

Affiliation: AstraZeneca

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: